Hemophilia A Drug Market Report

Europe Hemophilia A Drug Market Size, Status and Forecast 2014-2026

  • POSTDATE：Nov 13, 2019
  • PAGES：193
  • REPORT CODE：GMM378312
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Hemophilia A Drug market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.5% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Hemophilia A Drug Market Segmentations:

    By Player:

    • CSL Behring

    • Biogen Idec

    • Kedrion Biopharma

    • Emergent BioSolutions

    • Amarna Therapeutics

    • Pfizer

    • Alnylam Pharmaceuticals

    • Baxter International

    • Dong-A Socio

    • Novo Nordisk

    • Catalyst Biosciences

    • Bayer's

    • Inspiration Biopharmaceuticals

    • Grifols

    • Dimension Therapeutics

    By Type:

    • Recombinant Coagulation Factor Concentrates

    • Plasma Derived Coagulation Factor Concentrates

    • Desmopressin

    • Antifibrinolytic Agents

    By End-User:

    • Hospital Pharmacies

    • Retail Pharmacies

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Hemophilia A Drug Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Hemophilia A Drug Market Size and Growth Rate of Recombinant Coagulation Factor Concentrates from 2014 to 2026

    • 1.3.2 Europe Hemophilia A Drug Market Size and Growth Rate of Plasma Derived Coagulation Factor Concentrates from 2014 to 2026

    • 1.3.3 Europe Hemophilia A Drug Market Size and Growth Rate of Desmopressin from 2014 to 2026

    • 1.3.4 Europe Hemophilia A Drug Market Size and Growth Rate of Antifibrinolytic Agents from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Hemophilia A Drug Market Size and Growth Rate of Hospital Pharmacies from 2014 to 2026

    • 1.4.2 Europe Hemophilia A Drug Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

    • 1.4.3 Europe Hemophilia A Drug Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Hemophilia A Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Hemophilia A Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Hemophilia A Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Hemophilia A Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Hemophilia A Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Hemophilia A Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Hemophilia A Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Hemophilia A Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Hemophilia A Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Hemophilia A Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Hemophilia A Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Hemophilia A Drug Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Hemophilia A Drug Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Hemophilia A Drug by Major Types

      • 3.4.1 Market Size and Growth Rate of Recombinant Coagulation Factor Concentrates

      • 3.4.2 Market Size and Growth Rate of Plasma Derived Coagulation Factor Concentrates

      • 3.4.3 Market Size and Growth Rate of Desmopressin

      • 3.4.4 Market Size and Growth Rate of Antifibrinolytic Agents

    4 Segmentation of Hemophilia A Drug Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Hemophilia A Drug by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Hemophilia A Drug for Hospital Pharmacies

      • 4.4.2 Market Size and Growth Rate of Hemophilia A Drug for Retail Pharmacies

      • 4.4.3 Market Size and Growth Rate of Hemophilia A Drug for Others

    5 Market Analysis by Major Regions

    • 5.1 Europe Hemophilia A Drug Production Analysis by Top Regions

    • 5.2 Europe Hemophilia A Drug Consumption Analysis by Top Regions

    • 5.3 Europe Hemophilia A Drug Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Hemophilia A Drug Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Hemophilia A Drug Production, Import, Consumption and Export Analysis

      • 5.3.3 France Hemophilia A Drug Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Hemophilia A Drug Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Hemophilia A Drug Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Hemophilia A Drug Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Hemophilia A Drug Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Hemophilia A Drug Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Hemophilia A Drug Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Hemophilia A Drug Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Hemophilia A Drug Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Hemophilia A Drug Production, Import, Consumption and Export Analysis

    6 Product Circulation of Hemophilia A Drug Market among Top Countries

    • 6.1 Top 5 Export Countries in Hemophilia A Drug Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Hemophilia A Drug Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Hemophilia A Drug Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Hemophilia A Drug Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Hemophilia A Drug Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Hemophilia A Drug Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Hemophilia A Drug Landscape Analysis

    • 7.1 Germany Hemophilia A Drug Landscape Analysis by Major Types

    • 7.2 Germany Hemophilia A Drug Landscape Analysis by Major End-Users

    8. UK Hemophilia A Drug Landscape Analysis

    • 8.1 UK Hemophilia A Drug Landscape Analysis by Major Types

    • 8.2 UK Hemophilia A Drug Landscape Analysis by Major End-Users

    9. France Hemophilia A Drug Landscape Analysis

    • 9.1 France Hemophilia A Drug Landscape Analysis by Major Types

    • 9.2 France Hemophilia A Drug Landscape Analysis by Major End-Users

    10. Italy Hemophilia A Drug Landscape Analysis

    • 10.1 Italy Hemophilia A Drug Landscape Analysis by Major Types

    • 10.2 Italy Hemophilia A Drug Landscape Analysis by Major End-Users

    11. Spain Hemophilia A Drug Landscape Analysis

    • 11.1 Spain Hemophilia A Drug Landscape Analysis by Major Types

    • 11.2 Spain Hemophilia A Drug Landscape Analysis by Major End-Users

    12. Poland Hemophilia A Drug Landscape Analysis

    • 12.1 Poland Hemophilia A Drug Landscape Analysis by Major Types

    • 12.2 Poland Hemophilia A Drug Landscape Analysis by Major End-Users

    13. Russia Hemophilia A Drug Landscape Analysis

    • 13.1 Russia Hemophilia A Drug Landscape Analysis by Major Types

    • 13.2 Russia Hemophilia A Drug Landscape Analysis by Major End-Users

    14. Switzerland Hemophilia A Drug Landscape Analysis

    • 14.1 Switzerland Hemophilia A Drug Landscape Analysis by Major Types

    • 14.2 Switzerland Hemophilia A Drug Landscape Analysis by Major End-Users

    15. Turkey Hemophilia A Drug Landscape Analysis

    • 15.1 Turkey Hemophilia A Drug Landscape Analysis by Major Types

    • 15.2 Turkey Hemophilia A Drug Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Hemophilia A Drug Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Hemophilia A Drug Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Hemophilia A Drug Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Hemophilia A Drug Landscape Analysis by Top Countries

      • 16.3.1 Denmark Hemophilia A Drug Market Volume and Growth Rate

      • 16.3.2 Finland Hemophilia A Drug Market Volume and Growth Rate

      • 16.3.3 Norway Hemophilia A Drug Market Volume and Growth Rate

      • 16.3.4 Sweden Hemophilia A Drug Market Volume and Growth Rate

      • 16.3.6 Iceland Hemophilia A Drug Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Hemophilia A Drug Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Hemophilia A Drug Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Hemophilia A Drug Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Hemophilia A Drug Landscape Analysis by Top Countries

      • 17.3.1 Belgium Hemophilia A Drug Market Volume and Growth Rate

      • 17.3.2 Netherlands Hemophilia A Drug Market Volume and Growth Rate

      • 17.3.3 Luxembourg Hemophilia A Drug Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Hemophilia A Drug Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Hemophilia A Drug Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Hemophilia A Drug Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Hemophilia A Drug Landscape Analysis by Top Countries

      • 18.3.1 Estonia Hemophilia A Drug Market Volume and Growth Rate

      • 18.3.2 Latvia Hemophilia A Drug Market Volume and Growth Rate

      • 18.3.3 Lithuania Hemophilia A Drug Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 CSL Behring

      • 19.1.1 CSL Behring Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Biogen Idec

      • 19.2.1 Biogen Idec Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Kedrion Biopharma

      • 19.3.1 Kedrion Biopharma Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Emergent BioSolutions

      • 19.4.1 Emergent BioSolutions Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Amarna Therapeutics

      • 19.5.1 Amarna Therapeutics Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Pfizer

      • 19.6.1 Pfizer Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Alnylam Pharmaceuticals

      • 19.7.1 Alnylam Pharmaceuticals Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Baxter International

      • 19.8.1 Baxter International Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Dong-A Socio

      • 19.9.1 Dong-A Socio Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Novo Nordisk

      • 19.10.1 Novo Nordisk Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Catalyst Biosciences

      • 19.11.1 Catalyst Biosciences Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Bayer's

      • 19.12.1 Bayer's Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Inspiration Biopharmaceuticals

      • 19.13.1 Inspiration Biopharmaceuticals Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Grifols

      • 19.14.1 Grifols Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 Dimension Therapeutics

      • 19.15.1 Dimension Therapeutics Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    The List of Tables and Figures (Totals 80 Figures and 115 Tables)

    • Figure Product Picture

    • Figure Europe Hemophilia A Drug Market Size and Growth Rate of Recombinant Coagulation Factor Concentrates from 2014 to 2026

    • Figure Europe Hemophilia A Drug Market Size and Growth Rate of Plasma Derived Coagulation Factor Concentrates from 2014 to 2026

    • Figure Europe Hemophilia A Drug Market Size and Growth Rate of Desmopressin from 2014 to 2026

    • Figure Europe Hemophilia A Drug Market Size and Growth Rate of Antifibrinolytic Agents from 2014 to 2026

    • Figure Europe Hemophilia A Drug Market Size and Growth Rate of Hospital Pharmacies from 2014 to 2026

    • Figure Europe Hemophilia A Drug Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

    • Figure Europe Hemophilia A Drug Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany Hemophilia A Drug Market Size and Growth Rate from 2014 to 2026

    • Figure UK Hemophilia A Drug Market Size and Growth Rate from 2014 to 2026

    • Figure France Hemophilia A Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Hemophilia A Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Hemophilia A Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Hemophilia A Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Hemophilia A Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Hemophilia A Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Hemophilia A Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Hemophilia A Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Hemophilia A Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Hemophilia A Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Hemophilia A Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Hemophilia A Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Hemophilia A Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Hemophilia A Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Hemophilia A Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Hemophilia A Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Hemophilia A Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Hemophilia A Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Hemophilia A Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Hemophilia A Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Hemophilia A Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Hemophilia A Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Hemophilia A Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Hemophilia A Drug Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Hemophilia A Drug

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Hemophilia A Drug by Different Types from 2014 to 2026

    • Table Consumption Share of Hemophilia A Drug by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Recombinant Coagulation Factor Concentrates

    • Figure Market Size and Growth Rate of Plasma Derived Coagulation Factor Concentrates

    • Figure Market Size and Growth Rate of Desmopressin

    • Figure Market Size and Growth Rate of Antifibrinolytic Agents

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Hemophilia A Drug by Different End-Users from 2014 to 2026

    • Table Consumption Share of Hemophilia A Drug by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospital Pharmacies

    • Figure Market Size and Growth Rate of Retail Pharmacies

    • Figure Market Size and Growth Rate of Others

    • Table Europe Hemophilia A Drug Production by Major Regions

    • Table Europe Hemophilia A Drug Production Share by Major Regions

    • Figure Europe Hemophilia A Drug Production Share by Major Countries and Regions in 2014

    • Table Europe Hemophilia A Drug Consumption by Major Regions

    • Table Europe Hemophilia A Drug Consumption Share by Major Regions

    • Table Germany Hemophilia A Drug Production, Import, Consumption and Export Analysis

    • Table UK Hemophilia A Drug Production, Import, Consumption and Export Analysis

    • Table France Hemophilia A Drug Production, Import, Consumption and Export Analysis

    • Table Italy Hemophilia A Drug Production, Import, Consumption and Export Analysis

    • Table Spain Hemophilia A Drug Production, Import, Consumption and Export Analysis

    • Table Poland Hemophilia A Drug Production, Import, Consumption and Export Analysis

    • Table Russia Hemophilia A Drug Production, Import, Consumption and Export Analysis

    • Table Switzerland Hemophilia A Drug Production, Import, Consumption and Export Analysis

    • Table Turkey Hemophilia A Drug Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Hemophilia A Drug Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Hemophilia A Drug Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Hemophilia A Drug Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Hemophilia A Drug Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Hemophilia A Drug Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Hemophilia A Drug Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Hemophilia A Drug Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Hemophilia A Drug Consumption by Types from 2014 to 2026

    • Table Germany Hemophilia A Drug Consumption Share by Types from 2014 to 2026

    • Table Germany Hemophilia A Drug Consumption by End-Users from 2014 to 2026

    • Table Germany Hemophilia A Drug Consumption Share by End-Users from 2014 to 2026

    • Table UK Hemophilia A Drug Consumption by Types from 2014 to 2026

    • Table UK Hemophilia A Drug Consumption Share by Types from 2014 to 2026

    • Table UK Hemophilia A Drug Consumption by End-Users from 2014 to 2026

    • Table UK Hemophilia A Drug Consumption Share by End-Users from 2014 to 2026

    • Table France Hemophilia A Drug Consumption by Types from 2014 to 2026

    • Table France Hemophilia A Drug Consumption Share by Types from 2014 to 2026

    • Table France Hemophilia A Drug Consumption by End-Users from 2014 to 2026

    • Table France Hemophilia A Drug Consumption Share by End-Users from 2014 to 2026

    • Table Italy Hemophilia A Drug Consumption by Types from 2014 to 2026

    • Table Italy Hemophilia A Drug Consumption Share by Types from 2014 to 2026

    • Table Italy Hemophilia A Drug Consumption by End-Users from 2014 to 2026

    • Table Italy Hemophilia A Drug Consumption Share by End-Users from 2014 to 2026

    • Table Spain Hemophilia A Drug Consumption by Types from 2014 to 2026

    • Table Spain Hemophilia A Drug Consumption Share by Types from 2014 to 2026

    • Table Spain Hemophilia A Drug Consumption by End-Users from 2014 to 2026

    • Table Spain Hemophilia A Drug Consumption Share by End-Users from 2014 to 2026

    • Table Poland Hemophilia A Drug Consumption by Types from 2014 to 2026

    • Table Poland Hemophilia A Drug Consumption Share by Types from 2014 to 2026

    • Table Poland Hemophilia A Drug Consumption by End-Users from 2014 to 2026

    • Table Poland Hemophilia A Drug Consumption Share by End-Users from 2014 to 2026

    • Table Russia Hemophilia A Drug Consumption by Types from 2014 to 2026

    • Table Russia Hemophilia A Drug Consumption Share by Types from 2014 to 2026

    • Table Russia Hemophilia A Drug Consumption by End-Users from 2014 to 2026

    • Table Russia Hemophilia A Drug Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Hemophilia A Drug Consumption by Types from 2014 to 2026

    • Table Switzerland Hemophilia A Drug Consumption Share by Types from 2014 to 2026

    • Table Switzerland Hemophilia A Drug Consumption by End-Users from 2014 to 2026

    • Table Switzerland Hemophilia A Drug Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Hemophilia A Drug Consumption by Types from 2014 to 2026

    • Table Turkey Hemophilia A Drug Consumption Share by Types from 2014 to 2026

    • Table Turkey Hemophilia A Drug Consumption by End-Users from 2014 to 2026

    • Table Turkey Hemophilia A Drug Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Hemophilia A Drug Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Hemophilia A Drug Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Hemophilia A Drug Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Hemophilia A Drug Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Hemophilia A Drug Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Hemophilia A Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Hemophilia A Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Hemophilia A Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Hemophilia A Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Hemophilia A Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Hemophilia A Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Hemophilia A Drug Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Hemophilia A Drug Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Hemophilia A Drug Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Hemophilia A Drug Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Hemophilia A Drug Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Hemophilia A Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Hemophilia A Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Hemophilia A Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Hemophilia A Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Hemophilia A Drug Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Hemophilia A Drug Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Hemophilia A Drug Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Hemophilia A Drug Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Hemophilia A Drug Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Hemophilia A Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Hemophilia A Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Hemophilia A Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Hemophilia A Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of CSL Behring

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL Behring

    • Figure Sales and Growth Rate Analysis of CSL Behring

    • Figure Revenue and Market Share Analysis of CSL Behring

    • Table Product and Service Introduction of CSL Behring

    • Table Company Profile and Development Status of Biogen Idec

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen Idec

    • Figure Sales and Growth Rate Analysis of Biogen Idec

    • Figure Revenue and Market Share Analysis of Biogen Idec

    • Table Product and Service Introduction of Biogen Idec

    • Table Company Profile and Development Status of Kedrion Biopharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kedrion Biopharma

    • Figure Sales and Growth Rate Analysis of Kedrion Biopharma

    • Figure Revenue and Market Share Analysis of Kedrion Biopharma

    • Table Product and Service Introduction of Kedrion Biopharma

    • Table Company Profile and Development Status of Emergent BioSolutions

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Emergent BioSolutions

    • Figure Sales and Growth Rate Analysis of Emergent BioSolutions

    • Figure Revenue and Market Share Analysis of Emergent BioSolutions

    • Table Product and Service Introduction of Emergent BioSolutions

    • Table Company Profile and Development Status of Amarna Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amarna Therapeutics

    • Figure Sales and Growth Rate Analysis of Amarna Therapeutics

    • Figure Revenue and Market Share Analysis of Amarna Therapeutics

    • Table Product and Service Introduction of Amarna Therapeutics

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Alnylam Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alnylam Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Alnylam Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Alnylam Pharmaceuticals

    • Table Product and Service Introduction of Alnylam Pharmaceuticals

    • Table Company Profile and Development Status of Baxter International

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Baxter International

    • Figure Sales and Growth Rate Analysis of Baxter International

    • Figure Revenue and Market Share Analysis of Baxter International

    • Table Product and Service Introduction of Baxter International

    • Table Company Profile and Development Status of Dong-A Socio

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dong-A Socio

    • Figure Sales and Growth Rate Analysis of Dong-A Socio

    • Figure Revenue and Market Share Analysis of Dong-A Socio

    • Table Product and Service Introduction of Dong-A Socio

    • Table Company Profile and Development Status of Novo Nordisk

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk

    • Figure Sales and Growth Rate Analysis of Novo Nordisk

    • Figure Revenue and Market Share Analysis of Novo Nordisk

    • Table Product and Service Introduction of Novo Nordisk

    • Table Company Profile and Development Status of Catalyst Biosciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Catalyst Biosciences

    • Figure Sales and Growth Rate Analysis of Catalyst Biosciences

    • Figure Revenue and Market Share Analysis of Catalyst Biosciences

    • Table Product and Service Introduction of Catalyst Biosciences

    • Table Company Profile and Development Status of Bayer's

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer's

    • Figure Sales and Growth Rate Analysis of Bayer's

    • Figure Revenue and Market Share Analysis of Bayer's

    • Table Product and Service Introduction of Bayer's

    • Table Company Profile and Development Status of Inspiration Biopharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Inspiration Biopharmaceuticals

    • Figure Sales and Growth Rate Analysis of Inspiration Biopharmaceuticals

    • Figure Revenue and Market Share Analysis of Inspiration Biopharmaceuticals

    • Table Product and Service Introduction of Inspiration Biopharmaceuticals

    • Table Company Profile and Development Status of Grifols

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Grifols

    • Figure Sales and Growth Rate Analysis of Grifols

    • Figure Revenue and Market Share Analysis of Grifols

    • Table Product and Service Introduction of Grifols

    • Table Company Profile and Development Status of Dimension Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dimension Therapeutics

    • Figure Sales and Growth Rate Analysis of Dimension Therapeutics

    • Figure Revenue and Market Share Analysis of Dimension Therapeutics

    • Table Product and Service Introduction of Dimension Therapeutics

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US